About ODUM
Revolutionary Protein Structure Prediction
ODUM delivers 0.05% higher accuracy than AlphaFold, setting a new standard in the field of computational biology.
ODUM
Our Optimized Deep Understanding of Molecules (ODUM) system builds on AlphaFold's foundation, achieving 0.05% higher accuracy through improved neural network architectures and quantum computing integration.
Folding@Home
Folding@Home's distributed computing network harnesses millions of volunteer computers worldwide to simulate protein folding, providing the computational power needed for complex simulations.
Palantir
Palantir's data integration platform connects and analyzes the massive datasets generated by our research, helping identify patterns and accelerate discoveries in drug development and disease treatment.
Our Technology
Quantum-Enhanced Algorithms
ODUM leverages quantum computing principles to solve complex protein folding problems faster than ever before.
Learn moreDistributed Computing Network
Folding@Home's network of over 4 million computers provides the massive computational power needed for our simulations.
Learn moreData Integration Platform
Palantir's Foundry platform connects disparate data sources and enables advanced analytics across our research pipeline.
Learn moreMachine Learning Models
Our custom neural networks are trained on the world's largest protein structure datasets to achieve unprecedented accuracy.
Learn moreReal-time Visualization
Interactive 3D models allow researchers to explore protein structures and interactions in unprecedented detail.
Learn moreAPI Ecosystem
Our open API allows researchers worldwide to access our tools and contribute to the advancement of biomedical science.
Learn moreResearch & Impact
Disease Research
Our collaborative platform has accelerated research into Alzheimer's, cancer, and COVID-19 by providing unprecedented insights into protein structures involved in these diseases.
View research papersDrug Discovery
By combining ODUM's structural predictions with Palantir's data analysis, we've reduced drug discovery timelines by up to 60% in preliminary studies.
View case studies